A Neurologist’s Perspective on Understanding Myasthenia Gravis
| Autor: | Henry J. Kaminski, Loulwah Mukharesh |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Weakness business.industry medicine.medical_treatment Neuromuscular transmission Autoantibody Disease medicine.disease Myasthenia gravis Thymectomy medicine Surgery Decompensation Age of onset medicine.symptom Intensive care medicine business |
| Zdroj: | Thoracic Surgery Clinics. 29:133-141 |
| ISSN: | 1547-4127 |
| DOI: | 10.1016/j.thorsurg.2018.12.002 |
| Popis: | Myasthenia gravis (MG) is a disease of neuromuscular transmission caused by antibodies directed toward proteins concentrated at the neuromuscular junction. Mild to life-threatening weakness varies in severity over time and with level of activity. Therefore, clinical diagnosis is often challenging. MG may be categorized by autoantibody type, thymic pathologic condition, and age of onset. Treatments are tailored for each group. A key management concern is severe exacerbation of weakness resulting from infections or exposure to certain medications, including antibiotics, which may be severe enough to produce respiratory decompensation. The article reviews key diagnostic issues and treatment options. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|